Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The conclusion is that the cornea has two types of stem cells, with Lrig1+ cells being key for renewal in aging corneas, independent of CD44.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

miR-200c-3p could help diagnose and treat alopecia areata.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

White hair follicles in vitiligo have fewer and less functional melanocytes.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

SQSTM1 gene issues may increase the risk of alopecia areata.

Too much or too little selenium in the diet can cause hair loss and graying in mice.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Non-invasive swabbing is as effective as cutting hair for collecting scalp hair bacteria.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Claudin-1 is important for the barrier function and growth of hair.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Treatments for melanin disorders exist, but more effective options needed.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.